NCT07188948 (VISION2) is a clinical trial of Skin conditions in Skin, sponsored by Gabriel Sanchez.

Who is sponsoring NCT07188948?

NCT07188948 is sponsored by Gabriel Sanchez.

What drugs are being tested in NCT07188948?

Interventions in NCT07188948: Skin conditions, Skin Condition.

Is NCT07188948 still recruiting?

NCT07188948 is currently recruiting now. Last updated 23 September 2025.

Last reviewed 2025-09-23 · How we verify

NCT07188948: VISION2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

In Vivo Cross-Modal Imaging of Skin

Recruiting now Last updated 23 September 2025

What this trial tests

trial testing Skin conditions in Skin in 15 participants. Currently enrolling.

Timeline

2 September 2025

Primary endpoint
30 September 2025

30 September 2025

Quick facts

Lead sponsor	Gabriel Sanchez
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	15
Start date	2 September 2025
Primary completion	30 September 2025
Estimated completion	30 September 2025
Sites	1 location across United States

Drugs / interventions tested

Skin conditions
Skin Condition

Conditions studied

Skin — all drugs for Skin →

Sponsor

Gabriel Sanchez

Who can join

Adults 2 to 90, any sex, with Skin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of this study is to use VIO/FG-30350 ("VIO") to observe microscopic skin structure in people of different skin health at different anatomic locations and correlate microscopic features with macroscopic features.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Skin

Currently open trials in the same condition.

NCT07298382 — See the Impact Beem's Blue Light Therapy Has on Your Skin Health! · NA · recruiting
NCT04305691 — Trial of Ixazomib for Kaposi Sarcoma · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07188948 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gabriel Sanchez
Last refreshed: 23 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07188948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing